This firm's breakthrough has drawn investments from the biggest names in Big Pharma - With companies like Biogen, Sanofi, and Genentech pouring over $1 billion into it.

Unlock the details of this groundbreaking opportunity here...

M. Frederick Dwozan net worth and biography

M. Dwozan Biography and Net Worth

Director of Colony Bankcorp

M. Frederick Dwozan, Jr. is the President/CEO/Owner of the Medical Center Prescription Shop, and owner of other entities involved in providing care to critically ill patients with Home IV Therapy, Nutritional Support Service, Pain Management, Disease Management, Hospice care and Medical Equipment. He previously served as a Director of Colony Bank Dodge until the merger in 2008 and presently serves as an advisory board member of Colony Bank Dodge office since 2008. Mr. Dwozan has been a Director of Colony Bankcorp since January 2012.

How do I contact M. Frederick Dwozan?: The corporate mailing address for Mr. Dwozan and other Colony Bankcorp executives is 115 South Grant Street, Fitzgerald GA, 31750. Colony Bankcorp can also be reached via phone at (229) 426-6000 and via email at [email protected]. Learn More on M. Frederick Dwozan's contact information.
Has M. Frederick Dwozan been buying or selling shares of Colony Bankcorp?: M. Frederick Dwozan has not been actively trading shares of Colony Bankcorp during the last quarter. Most recently, on Tuesday, February 8th, M Frederick Dwozan bought 6,500 shares of Colony Bankcorp stock. The stock was acquired at an average cost of $16.50 per share, with a total value of $107,250.00. Learn More on M. Frederick Dwozan's trading history.
Who are Colony Bankcorp's active insiders?: Colony Bankcorp's insider roster includes Edward Bagwell, III (VP), M. Dwozan (Director), T. Fountain (CEO), M. Hoyle, Jr. (EVP), Meagan Mowry (Director), Matthew Reed (Director), Brian Schmitt (Vice Chairman), and Harold Wyatt (Director). Learn More on Colony Bankcorp's active insiders.
Are insiders buying or selling shares of Colony Bankcorp?: In the last twelve months, Colony Bankcorp insiders bought shares 12 times. They purchased a total of 8,714 shares worth more than $85,179.20. In the last twelve months, insiders at the financial services provider sold shares 3 times. They sold a total of 23,592 shares worth more than $248,951.92. The most recent insider tranaction occured on February, 23rd when EVP Leonard H Bateman Jr bought 1,009 shares worth more than $11,209.99. Insiders at Colony Bankcorp own 6.6% of the company. Learn More about insider trades at Colony Bankcorp.
Information on this page was last updated on 2/23/2024.

M. Frederick Dwozan Insider Trading History at Colony Bankcorp

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
2/8/2022	Buy	6,500	$16.50	$107,250.00
2/14/2013	Buy	1,000	$5.30	$5,300.00
1/28/2013	Buy	2,000	$5.25	$10,500.00

M. Frederick Dwozan Buying and Selling Activity at Colony Bankcorp

Colony Bankcorp Company Overview

Colony Bankcorp, Inc. operates as the bank holding company for Colony Bank that provides various banking products and services to commercial and consumer customers. The company offers deposit products, including demand, savings, and time deposits. It also provides loans to small and medium-sized businesses; residential and commercial construction, and land development loans; commercial real estate loans; commercial loans; agri-business and production loans; residential mortgage loans; home equity loans; and consumer loans. In addition, the company offers internet banking services, electronic bill payment services, safe deposit box rentals, telephone banking, credit and debit card services, and remote depository products, as well as access to a network of ATMs. The company was founded in 1975 and is headquartered in Fitzgerald, Georgia.

Today's Range

Now: $10.85

$10.68

$10.92

50 Day Range

MA: $11.02

$10.45

$11.68

2 Week Range

Now: $10.85

$8.59

$13.58

Volume

28,919 shs

Average Volume

38,595 shs

Market Capitalization

$190.53 million

P/E Ratio

8.75

Dividend Yield

4.17%

Beta

0.53

Jim Cramer’s “The Biggest Drug Ever”

From Behind the Markets | Ad